Works matching AU Zhong, Diansheng

Results: 64

Aumolertinib plus bevacizumab for untreated advanced NSCLC with EGFR sensitive mutation.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1595812

By:

Kong, Lingping;
Peng, Lina;
Yang, Xue;
Ma, Qing;
Zhang, Linlin;
Liu, Xia;
Zhong, Diansheng;
Meng, Fanlu

Publication type:

Article

Liver kinase B1/adenosine monophosphate-activated protein kinase signaling axis induces p21/WAF1 expression in a p53-dependent manner.

Published in:

Oncology Letters, 2018, v. 16, n. 1, p. 1291, doi. 10.3892/ol.2018.8741

By:

Ma, Qing;
Xiao, Ping;
Sun, Linlin;
Wang, Jing;
Zhong, Diansheng

Publication type:

Article

EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma.

Published in:

OncoTargets & Therapy, 2015, v. 8, p. 3017, doi. 10.2147/OTT.S87146

By:

Yaoyao Ren;
Yibing Yao;
Qing Ma;
Diansheng Zhong

Publication type:

Article

The chalcone 2′-hydroxy-4′,5′-dimethoxychalcone activates death receptor 5 pathway and leads to apoptosis in human nonsmall cell lung cancer cells.

Published in:

IUBMB Life, 2013, v. 65, n. 6, p. 533, doi. 10.1002/iub.1161

By:

Yang, Lina;
Su, Ling;
Cao, Congmei;
Xu, Linyan;
Zhong, Diansheng;
Xu, Lijia;
Liu, Xiangguo

Publication type:

Article

CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression.

Published in:

Cell Death & Disease, 2024, v. 15, n. 5, p. 1, doi. 10.1038/s41419-024-06745-z

By:

Zhao, Ran;
Guo, Yanxuan;
Zhang, Linlin;
Huang, Zhiyong;
Li, Xuanyuan;
Lan, Bei;
Zhong, Diansheng;
Chen, Hao;
Xuan, Chenghao

Publication type:

Article

Lonafarnib Is a Potential Inhibitor for Neovascularization.

Published in:

PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0122830

By:

Sun, Linlin;
Xie, Songbo;
Peng, Guoyuan;
Wang, Jian;
Li, Yuanyuan;
Qin, Juan;
Zhong, Diansheng

Publication type:

Article

Antiangiogenic Agents Combined with Chemotherapy in the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Overall and Histology Subgroup-Specific Meta-Analysis.

Published in:

Oncology Research & Treatment, 2014, v. 37, n. 12, p. 710, doi. 10.1159/000369546

By:

Zhang, Linlin;
Cao, Feifei;
Wang, Yan;
Wang, Shuang;
Zhong, Diansheng

Publication type:

Article

Selective degradation of the p53‐R175H oncogenic hotspot mutant by an RNA aptamer‐based PROTAC.

Published in:

Clinical & Translational Medicine, 2023, v. 13, n. 2, p. 1, doi. 10.1002/ctm2.1191

By:

Kong, Lingping;
Meng, Fanlu;
Wu, Sijin;
Zhou, Ping;
Ge, Ruixin;
Liu, Min;
Zhang, Linlin;
Zhou, Jun;
Zhong, Diansheng;
Xie, Songbo

Publication type:

Article

Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy.

Published in:

BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11070-3

By:

Gao, Ai;
Guan, Shasha;
Sun, Yinjuan;
Wang, Lingling;
Meng, Fanlu;
Liu, Xia;
Gu, Liyan;
Li, Guo;
Zhong, Diansheng;
Zhang, Linlin

Publication type:

Article

EGFR p.V774M/p.L833V compound mutations in lung adenocarcinoma responded well to almonertinib: a case report.

Published in:

Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1159308

By:

Hai Pan;
Linlin Zhang;
Fanlu Meng;
Shasha Guan;
Diansheng Zhong

Publication type:

Article

2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells.

Published in:

PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0168793

By:

Sun, Linlin;
Liu, Xiuju;
Fu, Haian;
Zhou, Wei;
Zhong, Diansheng

Publication type:

Article

Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells.

Published in:

Journal of Cellular & Molecular Medicine, 2012, v. 16, n. 7, p. 1618, doi. 10.1111/j.1582-4934.2011.01401.x

By:

Liu, Guangbo;
Su, Ling;
Hao, Xuexi;
Zhong, Ning;
Zhong, Diansheng;
Singhal, Sunil;
Liu, Xiangguo

Publication type:

Article

Retrospective study of EGFR‐mutant lung adenocarcinoma with bone metastatic clinical features.

Published in:

Cancer Reports, 2023, v. 6, n. 1, p. 1, doi. 10.1002/cnr2.1628

By:

Gu, Liyan;
Gong, Ting;
Ma, Qing;
Zhong, Diansheng

Publication type:

Article

A deep learning‐based interpretable decision tool for predicting high risk of chemotherapy‐induced nausea and vomiting in cancer patients prescribed highly emetogenic chemotherapy.

Published in:

Cancer Medicine, 2023, v. 12, n. 17, p. 18306, doi. 10.1002/cam4.6428

By:

Zhang, Jingyue;
Cui, Xudong;
Yang, Chong;
Zhong, Diansheng;
Sun, Yinjuan;
Yue, Xiaoxiong;
Lan, Gaoshuang;
Zhang, Linlin;
Lu, Liangfu;
Yuan, Hengjie

Publication type:

Article

Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells.

Published in:

Autophagy, 2013, v. 9, n. 7, p. 1057, doi. 10.4161/auto.24632

By:

Tianliang Li;
Ling Su;
Ning Zhong;
Xuexi Hao;
Diansheng Zhong;
Sunil Singhal;
Xiangguo Liu

Publication type:

Article

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1143, doi. 10.1111/1759-7714.14370

By:

Jia, Bin;
Gong, Ting;
Sun, Bingsheng;
Zhang, Zhenfa;
Zhong, Diansheng;
Wang, Changli

Publication type:

Article

Targeting the EMT transcription factor Snail overcomes resistance to osimertinib in EGFR‐mutant non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2021, v. 12, n. 11, p. 1708, doi. 10.1111/1759-7714.13906

By:

Qin, Qiong;
Li, Xiaoqing;
Liang, Xingmei;
Zeng, Lili;
Wang, Jing;
Sun, Linlin;
Zhong, Diansheng

Publication type:

Article

Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte‐colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study.

Published in:

Thoracic Cancer, 2021, v. 12, n. 8, p. 1154, doi. 10.1111/1759-7714.13883

By:

Liu, Chang;
Hao, Ying;
Wang, Lei;
Meng, Fanlu;
Wen, Fuyu;
Zhong, Diansheng

Publication type:

Article

CDK4/6 inhibitor palbociclib overcomes acquired resistance to third‐generation EGFR inhibitor osimertinib in non‐small cell lung cancer (NSCLC).

Published in:

Thoracic Cancer, 2020, v. 11, n. 9, p. 2389, doi. 10.1111/1759-7714.13521

By:

Qin, Qiong;
Li, Xiaoqing;
Liang, Xingmei;
Zeng, Lili;
Wang, Jing;
Sun, Linlin;
Zhong, Diansheng

Publication type:

Article

Molecular mechanism of acquired drug resistance in the EGFR‐TKI resistant cell line HCC827‐TR.

Published in:

Thoracic Cancer, 2020, v. 11, n. 5, p. 1129, doi. 10.1111/1759-7714.13342

By:

Yu, Tao;
Xia, Qian;
Gong, Ting;
Wang, Jing;
Zhong, DianSheng

Publication type:

Article

EGFR exon 19‐deletion aberrantly regulate ERCC1 expression that may partly impaired DNA damage repair ability in non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2020, v. 11, n. 2, p. 277, doi. 10.1111/1759-7714.13253

By:

Zhang, Linlin;
Pradhan, Barun;
Guo, Lili;
Meng, Fanlu;
Zhong, Diansheng

Publication type:

Article

High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.

Published in:

Thoracic Cancer, 2019, v. 10, n. 5, p. 1103, doi. 10.1111/1759-7714.13051

By:

Li, Xiaoqing;
Liu, Meirong;
Zhang, Zheng;
Zhang, Linlin;
Liang, Xingmei;
Sun, Linlin;
Zhong, Diansheng

Publication type:

Article

Retrospective study of the efficacy and toxicity of lobaplatin‐etoposide chemotherapy in small cell lung cancer.

Published in:

Thoracic Cancer, 2019, v. 10, n. 2, p. 226, doi. 10.1111/1759-7714.12936

By:

Gu, Liyan;
Zhong, Diansheng;
Yu, Tao;
Tang, Ping;
Meng, Fanlu;
Qin, Qiong

Publication type:

Article

Concurrent epidermal growth factor receptor T790 M secondary mutation and epithelial-mesenchymal transition in a lung adenocarcinoma patient with EGFR- TKI drug resistance.

Published in:

Thoracic Cancer, 2017, v. 8, n. 6, p. 693, doi. 10.1111/1759-7714.12484

By:

Xu, Song;
Liu, Xia;
Liu, Renwang;
Shi, Tao;
Li, Xiongfei;
Zhong, Diansheng;
Wang, Yan;
Chen, Gang;
Chen, Jun

Publication type:

Article

Comparing the adverse effects of platinum in combination with etoposide or irinotecan in previously untreated small-cell lung cancer patients with extensive disease: A network meta-analyses.

Published in:

Thoracic Cancer, 2017, v. 8, n. 3, p. 170, doi. 10.1111/1759-7714.12420

By:

Chen, Yujie;
Chen, Lingxiao;
Zhong, Diansheng

Publication type:

Article

Giant solitary fibrous tumor of the lung: A case report.

Published in:

Thoracic Cancer, 2014, v. 5, n. 3, p. 261, doi. 10.1111/1759-7714.12069

By:

Xiao, Ping;
Sun, Linlin;
Zhong, Diansheng;
Lian, Linjuan;
Xu, Dongbo

Publication type:

Article

Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity.

Published in:

International Journal of Biological Sciences, 2023, v. 19, n. 3, p. 981, doi. 10.7150/ijbs.79852

By:

Shuang Zheng;
Jiaming Song;
Dongli Linghu;
Riyao Yang;
Boning Liu;
Zhen Xue;
Qihui Chen;
Chengjie Liu;
Diansheng Zhong;
Mien-Chie Hung;
Linlin Sun

Publication type:

Article

Homologous recombination deficiency status predicts response to immunotherapy‐based treatment in non‐small cell lung cancer patients.

Published in:

Thoracic Cancer, 2024, v. 15, n. 25, p. 1842, doi. 10.1111/1759-7714.15408

By:

Gao, Ai;
Wang, Xin;
Wang, Jing;
Zhong, Diansheng;
Zhang, Linlin

Publication type:

Article

EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1.

Published in:

Cell Cycle, 2008, v. 7, n. 15, p. 2409, doi. 10.4161/cc.6410

By:

Thomas, Shala L.;
Diansheng Zhong;
Wei Zhou;
Malik, Sanna;
Liotta, Dennis;
Snyder, James P.;
Hamel, Ernest;
Giannakakou, Paraskevi

Publication type:

Article

Difficult differential diagnosis of bladder pedicled masses about metastasis from non-small cell lung cancer: A case report.

Published in:

2021

By:

Li, Xiaoqing;
Zhang, Linlin;
Zeng, Lili;
Wang, Xin;
Song, Wenjing;
Zhong, Diansheng

Publication type:

Report

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study.

Published in:

Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01823-w

By:

Zhang, Linlin;
Wang, Liuchun;
Wang, Jingya;
Chen, Jinliang;
Meng, Zhaoting;
Liu, Zhujun;
Jiang, Xiangli;
Wang, Xinyue;
Huang, Chun;
Chen, Peng;
Liang, Yan;
Jiang, Richeng;
Wang, Jing;
Zhong, Diansheng;
Shang, Yanhong;
Zhang, Yan;
Zhang, Cuiying;
Huang, Dingzhi

Publication type:

Article

Nomogram for predicting opioid-induced nausea and vomiting for cancer pain patients.

Published in:

Supportive Care in Cancer, 2023, v. 31, n. 12, p. 1, doi. 10.1007/s00520-023-08144-0

By:

Kong, Lingping;
Wang, Jing;
Guan, Shasha;
Chen, Xiaochen;
Li, Meiqing;
Gao, Liming;
Zhong, Diansheng;
Zhang, Linlin

Publication type:

Article

Nomogram for predicting opioid-induced nausea and vomiting for cancer pain patients.

Published in:

Supportive Care in Cancer, 2023, v. 31, n. 11, p. 1, doi. 10.1007/s00520-023-08144-0

By:

Kong, Lingping;
Wang, Jing;
Guan, Shasha;
Chen, Xiaochen;
Li, Meiqing;
Gao, Liming;
Zhong, Diansheng;
Zhang, Linlin

Publication type:

Article

Case Report: Dramatic Response to Crizotinib in a Patient With Non-Small Cell Lung Cancer Positive for a Novel ARL1-MET Fusion.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.804330

By:

Ma, Qing;
Kong, Lingping;
Zhong, Diansheng

Publication type:

Article

A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy.

Published in:

Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.1068978

By:

Shasha Guan;
Linlin Zhang;
Junyan Zhang;
Wenjing Song;
Diansheng Zhong

Publication type:

Article

Correlation Analysis between Neutrophil-to-lymphocyte Ratio and the Risk of Malnutrition in Stage IV Primary Lung Cancer.

Published in:

Chinese Journal of Lung Cancer, 2024, v. 27, n. 3, p. 193, doi. 10.3779/j.issn.1009-3419.2024.106.06

By:

Ping XIAO;
Hai PAN;
Qing MA;
Liping SONG;
Diansheng ZHONG

Publication type:

Article

Research Progress of BRAF Fusion in Non-small Cell Lung Cancer.

Published in:

Chinese Journal of Lung Cancer, 2023, v. 26, n. 10, p. 782, doi. 10.3779/j.issn.1009-3419.2023.101.28

By:

Ping XIAO;
Diansheng ZHONG

Publication type:

Article

Research Progress of Klotho in Lung Neoplasms.

Published in:

Chinese Journal of Lung Cancer, 2023, v. 26, n. 6, p. 473, doi. 10.3779/j.issn.1009-3419.2023.102.19

By:

Jing WANG;
Lili ZENG;
Lingping KONG;
Linlin ZHANG;
Jun CHEN;
Diansheng ZHONG;
Yaguang FAN

Publication type:

Article

Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review.

Published in:

Chinese Journal of Lung Cancer, 2023, v. 26, n. 2, p. 158, doi. 10.3779/j.issn.1009-3419.2023.101.04

By:

Xue YANG;
Fanlu MENG;
Diansheng ZHONG

Publication type:

Article

DNA Damage Repair System and Antineoplastic Agents in Lung Cancer.

Published in:

Chinese Journal of Lung Cancer, 2022, v. 25, n. 6, p. 434, doi. 10.3779/j.issn.1009-3419.2022.101.24

By:

Linlin ZHANG;
Fanlu MENG;
Diansheng ZHONG

Publication type:

Article

Two Case Reports of Type 2 Diabetes Induced by Immune Checkpoint Inhibitors Combined with Chemotherapy.

Published in:

Chinese Journal of Lung Cancer, 2022, v. 25, n. 4, p. 287, doi. 10.3779/j.issn.1009-3419.2022.102.10

By:

Ping XIAO;
Linlin ZHANG;
Yu WANG;
Fanlu MENG;
Xin WANG;
Diansheng ZHONG

Publication type:

Article

Immune Checkpoint Inhibitors Related Diabetes Mellitus: A Report of 2 Cases and Literature Review.

Published in:

Chinese Journal of Lung Cancer, 2022, v. 25, n. 1, p. 61, doi. 10.3779/j.issn.1009-3419.2021.102.54

By:

Yaoyao Ren;
Linlin Zhang;
Yu Wang;
Diansheng Zhong

Publication type:

Article

Research Progress of Targeted Therapy for HER2 Gene in Advanced Non-small Cell Lung Cancer.

Published in:

Chinese Journal of Lung Cancer, 2020, v. 23, n. 12, p. 1108, doi. 10.3779/j.issn.1009-3419.2020.101.49

By:

Lingping KONG;
Diansheng ZHONG

Publication type:

Article

Gene Fusions as Acquired Resistance Mechanisms of EGFR-TKI.

Published in:

Chinese Journal of Lung Cancer, 2020, v. 23, n. 5, p. 381, doi. 10.3779/j.issn.1009-3419.2020.101.04

By:

Yi SHAO;
Diansheng ZHONG

Publication type:

Article

Research Progress of CDK4/6 Inhibitors in Non-small Cell Lung Cancer.

Published in:

Chinese Journal of Lung Cancer, 2020, v. 23, n. 3, p. 176, doi. 10.3779/j.issn.1009-3419.2020.03.07

By:

Qiong QIN;
Yaoyao REN;
Diansheng ZHONG

Publication type:

Article

Research Progress of Immune Checkpoint Inhibitor Therapy for BRAF Mutation in Non-small Cell Lung Cancer.

Published in:

Chinese Journal of Lung Cancer, 2019, v. 22, n. 9, p. 583, doi. 10.3779/j.issn.1009-3419.2019.09.06

By:

Xia LIU;
Diansheng ZHONG

Publication type:

Article

Immunotherapy in Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer.

Published in:

Chinese Journal of Lung Cancer, 2019, v. 22, n. 8, p. 541, doi. 10.3779/j.issn.1009-3419.2019.08.11

By:

Xin WANG;
Diansheng ZHONG

Publication type:

Article

Advanced Research on Non-small Cell Lung Cancer with De Novo T790M Mutation.

Published in:

Chinese Journal of Lung Cancer, 2019, v. 22, n. 5, p. 324, doi. 10.3779/j.issn.1009-3419.2019.05.10

By:

Xin WANG;
Diansheng ZHONG

Publication type:

Article

Molecular Mechanism and Progression of Primary Resistance to EGFR-TKI - Analysis of 2 Cases.

Published in:

Chinese Journal of Lung Cancer, 2019, v. 22, n. 1, p. 52, doi. 10.3779/j.issn.1009-3419.2019.01.10

By:

Meirong LIU;
Fanlu MENG;
Qing MA;
Liyan GU;
Diansheng ZHONG

Publication type:

Article

Clinical Development of Immunotherapy for Small Cell Lung Cancer.

Published in:

Chinese Journal of Lung Cancer, 2018, v. 21, n. 12, p. 918, doi. 10.3779/j.issn.1009-3419.2018.12.10

By:

Tao YU;
Diansheng ZHONG

Publication type:

Article